Financhill
Back

Allakos Quote, Financials, Valuation and Earnings

Allakos Price Quote

$1.22
+0.00 (+-5.43%)
(Updated: December 21, 2024 at 5:14 AM ET)

Allakos Key Stats

Sell
34
Allakos (ALLK) is a Sell

Day range:
$1.22 - $1.38
52-week range:
$0.54 - $3.36
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.49%

Volume:
473K
Avg. volume:
460.8K
1-year change:
-53.98%
Market cap:
$108.6M
Revenue:
$0
EPS:
$-2.04

How Much Does Allakos Make?

Data Unavailable

Is Allakos Growing As A Company?

Data Unavailable

Allakos Stock Price Performance

  • Did Allakos Stock Go Up Last Month?
    Allakos share price went up by 29.37% last month
  • Did ALLK's Share Price Rise Over The Last Year?
    ALLK share price fell by -53.98% over the past 1 year

What Is Allakos 52-Week High & Low?

  • What Is Allakos’s 52-Week High Share Price?
    Allakos has traded as high as $3.36 over the past 52 weeks
  • What Is Allakos’s 52-Week Low Share Price?
    Allakos has traded as low as $0.54 over the past 52 weeks

Allakos Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Allakos?

Data Unavailable

Is Allakos Cash Flow Positive?

Data Unavailable

Allakos Return On Invested Capital

Data Unavailable

Allakos Earnings Date & Stock Price

  • What Is Allakos's Stock Price Today?
    A single share of ALLK can be purchased today for 1.22
  • What Is Allakos’s Stock Symbol?
    Allakos trades on the nasdaq under the ticker symbol: ALLK
  • When Is Allakos’s Next Earnings Date?
    The next quarterly earnings date for Allakos is scheduled on March 14, 2025
  • When Is ALLK's next ex-dividend date?
    Allakos's next ex-dividend date is December 22, 2024
  • How To Buy Allakos Stock?
    You can buy Allakos shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Allakos Competitors

  • Who Are Allakos's Competitors?
    Below is a list of companies who compete with Allakos or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Allakos Dividend Yield

Data Unavailable

Allakos Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 15.26%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 3.35
Upside from Last Price: 175.72%

Major Shareholders

Data Unavailable